28 clinical trials matched your search for Skin Cancer. You can click one of the clinical trials below for more information, or click the Search Again button to enter different search text.

Search Again
Condition Study Title Investigator
Skin Cancer Cemiplimab Survivorship Epidemiology (CASE) Study Richard Carvajal, MD
Skin Cancer Study of Cemiplimab in Cutaneous Squamous Cell Carcinoma Shaheer Khan, DO
Melanoma IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma Richard Carvajal, MD
Melanoma CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma Benjamin Izar, MD
Melanoma Study of SD-101 in Patients with Metastatic Uveal Melanoma (Eye Cancer) with Liver Disease Shaheer Khan, DO
Melanoma Study of AU-011 in Patients with Melanoma or Lesion in the Eye Brian Marr, MD
Melanoma A First-in-Human Study Using FHD-286 in Patients with Metastatic Uveal Melanoma Richard Carvajal, MD
Melanoma Study of ALKS 4230 in Patients with Previously Treated Advanced Melanoma Benjamin Izar, MD
Squamous Cell Carcinoma Study of Ruxolitinib in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma Richard Carvajal, MD
Prostate Cancer Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer Mark Stein, MD
Cancer Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) Brian Henick, MD
Cancer TCR-engineered T Cells in Solid Tumors (ACTengine) Ran Reshef, MD
Pancreatic Cancer Chemo4METPANC: Combination Chemotherapy (Gemcitabine and Nab-Paclitaxel), Motixafortide, and Cemiplimab in Pancreas Adenocarcinoma Gulam Manji, MD, PhD
Cancer Study of RTX-240 in Adults with Relapsed/Refractory or Locally Advanced Solid Tumors Mark Stein, MD
Cancer Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers Benjamin Izar, MD
Sarcoma Study of Envafolimab in Patients with Sarcoma or Myxofibrosarcoma Gary Schwartz, MD
Cancer A Study of ASP9801 in Patients With Advanced Metastatic Solid Tumors Matthew Ingham, MD
Cancer Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Brian Henick, MD
Autoimmune Disorders Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer Brian Henick, MD
Cancer COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors Benjamin Izar, MD
Brain Tumors Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma Mary Welch, MD
Brain Cancer Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma Mary Welch, MD
Cancer Molecular Analysis for Therapy Choice (MATCH) Richard Carvajal, MD
Cancer Smartphone App for Cancer Medication Adherence Melissa Accordino, MD
Cancer A First-in-Human Study of CDK-002 (exoSTING) in Subjects with Advanced/Metastatic Solid Tumors Matthew Ingham, MD
Cancer Study of New Oral Anti-Cancer Drug (OACD) Dawn Hershman, MD
Cancer First-in-Human Study of DS-7300a in Subjects with Advanced Cancer Mark Stein, MD
Cancer Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses Dawn Hershman, MD